Details
Title
Author Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia
Author
Kewan, Tariq 1
; Durmaz, Arda 2 ; Bahaj, Waled 3 ; Gurnari, Carmelo 4
; Terkawi, Laila 3 ; Awada, Hussein 3
; Ogbue, Olisaemeka D. 3
; Ahmed, Ramsha 3 ; Pagliuca, Simona 5 ; Awada, Hassan 6 ; Kubota, Yasuo 3 ; Mori, Minako 3
; Ponvilawan, Ben 3 ; Al-Share, Bayan 7 ; Patel, Bhumika J. 3 ; Carraway, Hetty E. 3
; Scott, Jacob 2 ; Balasubramanian, Suresh K. 7 ; Bat, Taha 8 ; Madanat, Yazan 8
; Sekeres, Mikkael A. 9 ; Haferlach, Torsten 10
; Visconte, Valeria 3
; Maciejewski, Jaroslaw P. 3
1 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); Yale University, Department of Hematology and Medical Oncology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
2 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); Case Western Reserve University, Systems Biology and Bioinformatics Department, School of Medicine, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
3 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725)
4 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); University of Rome Tor Vergata, Department of Biomedicine and Prevention, Ph.D. in Immunology, Molecular Medicine and Applied Biotechnology, Rome, Italy (GRID:grid.6530.0) (ISNI:0000 0001 2300 0941)
5 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); CHRU de Nancy, Department of Clinical Hematology, Nancy, France (GRID:grid.410527.5) (ISNI:0000 0004 1765 1301)
6 Roswell Park Comprehensive Cancer Center, Buffalo, USA (GRID:grid.410527.5) (ISNI:0000 0001 2181 8635)
7 Wayne State University, Department of Hematology and Oncology, Karmanos Cancer Institute, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
8 University of Texas Southwestern Medical Center, Department of Internal Medicine, Division of Hematology and Oncology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
9 University of Miami, Division of Hematology, Sylvester Cancer Center, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)
10 MLL Munich Leukemia Laboratory, Munich, Germany (GRID:grid.420057.4) (ISNI:0000 0004 7553 8497)
; Durmaz, Arda 2 ; Bahaj, Waled 3 ; Gurnari, Carmelo 4
; Terkawi, Laila 3 ; Awada, Hussein 3
; Ogbue, Olisaemeka D. 3
; Ahmed, Ramsha 3 ; Pagliuca, Simona 5 ; Awada, Hassan 6 ; Kubota, Yasuo 3 ; Mori, Minako 3
; Ponvilawan, Ben 3 ; Al-Share, Bayan 7 ; Patel, Bhumika J. 3 ; Carraway, Hetty E. 3
; Scott, Jacob 2 ; Balasubramanian, Suresh K. 7 ; Bat, Taha 8 ; Madanat, Yazan 8
; Sekeres, Mikkael A. 9 ; Haferlach, Torsten 10
; Visconte, Valeria 3
; Maciejewski, Jaroslaw P. 3
1 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); Yale University, Department of Hematology and Medical Oncology, New Haven, USA (GRID:grid.47100.32) (ISNI:0000 0004 1936 8710)
2 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); Case Western Reserve University, Systems Biology and Bioinformatics Department, School of Medicine, Cleveland, USA (GRID:grid.67105.35) (ISNI:0000 0001 2164 3847)
3 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725)
4 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); University of Rome Tor Vergata, Department of Biomedicine and Prevention, Ph.D. in Immunology, Molecular Medicine and Applied Biotechnology, Rome, Italy (GRID:grid.6530.0) (ISNI:0000 0001 2300 0941)
5 Taussig Cancer Institute, Cleveland Clinic, Department of Translational Hematology and Oncology Research, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725); CHRU de Nancy, Department of Clinical Hematology, Nancy, France (GRID:grid.410527.5) (ISNI:0000 0004 1765 1301)
6 Roswell Park Comprehensive Cancer Center, Buffalo, USA (GRID:grid.410527.5) (ISNI:0000 0001 2181 8635)
7 Wayne State University, Department of Hematology and Oncology, Karmanos Cancer Institute, Detroit, USA (GRID:grid.254444.7) (ISNI:0000 0001 1456 7807)
8 University of Texas Southwestern Medical Center, Department of Internal Medicine, Division of Hematology and Oncology, Dallas, USA (GRID:grid.267313.2) (ISNI:0000 0000 9482 7121)
9 University of Miami, Division of Hematology, Sylvester Cancer Center, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606)
10 MLL Munich Leukemia Laboratory, Munich, Germany (GRID:grid.420057.4) (ISNI:0000 0004 7553 8497)
Pages
1184
Publication year
2024
Publication date
2024
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2923574046
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.